Adam J Schoenfeld Selected Research

Adam J Schoenfeld Research Topics

22	Neoplasms (Cancer) 04/2024 - 01/2020
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 01/2019
15	Lung Neoplasms (Lung Cancer) 01/2024 - 01/2019
5	Adenocarcinoma of Lung 01/2023 - 01/2019
3	Colitis 03/2024 - 09/2023
2	Ulcerative Colitis 03/2024 - 09/2023
2	Genetic Risk Score 03/2024 - 09/2023
2	Aneuploidy (Aneuploid) 11/2023 - 11/2023
2	Disease Progression 01/2023 - 01/2021
1	Inflammation (Inflammations) 01/2024
1	Dysbiosis 12/2023
1	Turcot syndrome 10/2023
1	Microsatellite Instability 10/2023
1	Cytokine Release Syndrome 01/2023
1	COVID-19 01/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Carcinogenesis 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 03/2021
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2019

11	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2020
6	osimertinibIBA 01/2023 - 01/2020
5	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2019
4	Biomarkers (Surrogate Marker)IBA 11/2023 - 10/2022
3	durvalumabIBA 11/2023 - 01/2023
3	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2019
2	B7-H1 AntigenIBA 11/2023 - 01/2023
2	dacomitinibIBA 09/2022 - 01/2021
2	lorlatinibIBA 01/2021 - 01/2020
2	entrectinibIBA 01/2021 - 01/2020
2	CrizotinibIBA 01/2021 - 01/2020
2	Bevacizumab (Avastin)FDA Link 12/2020 - 01/2020
1	Interleukin-2 (IL2)IBA 02/2024
1	InterferonsIBA 01/2024
1	PlatinumIBA 11/2023
1	RNA (Ribonucleic Acid)IBA 11/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	IpilimumabIBA 01/2023
1	NivolumabIBA 01/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	pembrolizumabIBA 10/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	ChromatinIBA 01/2022
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	src-Family KinasesIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 03/2021
1	cabozantinibIBA 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020
1	SolventsIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	repotrectinibIBA 01/2020
1	ceritinibIBA 01/2020
1	cyclo(Arg-Pro) (CI 4)IBA 01/2020
1	Bortezomib (Velcade)FDA Link 01/2019
1	Proteasome InhibitorsIBA 01/2019

12	Therapeutics 04/2024 - 01/2019
7	Immunotherapy 04/2024 - 11/2020
3	Drug Therapy (Chemotherapy) 11/2023 - 01/2023
2	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2024 - 02/2024
1	Fecal Microbiota Transplantation 12/2023
1	Artificial Respiration (Mechanical Ventilation) 01/2023
1	Precision Medicine 10/2022
1	Complementary Therapies (Alternative Medicine) 01/2021